DOVER, DE--(NewMediaWire - May 22, 2017) - Metatron (OTC
PINK: MRNJ), an emerging pioneer of releasing
Marijuana & CBD related apps on iTunes and Google Play, is
pleased to announce it is entering the Health and Wellness markets
of Cannabonoid extracts and seeks to specialize in the development
of cannabinoid-based products and is making plans to enter the
Multi-Billion Dollar coffee markets with its own single serve
coffee maker and specialty blend of CBD infused Coffee. This single
serve coffee maker is complete with a wire based filter for easy
cleaning and will come with our line of CBD infused specialty
coffee as an initial order package deal that will be soon available
at Amazon.com.
"We are already underway making these announced plans a reality
for our shareholders and the planned CBD coffee comes from the
highest quality coffee beans, responsibly sourced, freshly
blind-roasted, and infused with solvent-free, full-spectrum CBD
extract. Our CBD oil is extracted from the whole hemp plant by a
supercritical CO2 process. It is the high CBD and high cannabinoid
content oil extracted from the whole plant that we call Full
Spectrum CBD Oil," stated CEO and President of Metatron Joe
Riehl.
CBD, or Cannabidiol, is the non-psychoactive compound found in
the cannabis sativa plant (Industrial Hemp). For many, the health
benefits of adding CBD to their diet results in positive effects to
the body's endocannabinoid system -- the vast network of CB1 and
CB2 receptors and other receptors within the body and system
naturally found in the human body. CBD has been known to help ease
chronic pain, anxiety, among other ailments.
"The Burgeoning coffee market is ripe for Cann-A-Coffee our
first addition to our upcoming Cannabis infused health and wellness
products," stated CEO Joe Riehl. The coffee market in the
United States consists of roughly 100 million users, of those users
30 million drink specialty brand coffees. Statistics show that the
total amount of yearly money spent on specialty coffee in the U.S.
is a whopping 18 billion dollars.
In keeping with Metatron (MRNJ) planned strategy for continued
growth into the Cannabis and Cannabis extracts markets, the
Specialty Coffee market is the logical step that will go hand in
hand with our development of even more Health and Wellness products
to soon be added to a growing market segment.
In a peer-reviewed study published in the British Journal of
Pharmacology, several cannabinoids -- including
non-psychoactive cannabidiol (CBD), cannabigerol (CBG) and cannabidivarin
(CBV) -- appear to have the ability to "switch off"
uncontrolled skin cell growth. This kind of uncontrolled growth is
a factor in skin cancers and skin allergies. In
the study, researchers recorded the effects of
three cannabinoids -- cannabidiol (CBD),
cannabigerol (CBG) and cannabidivarin (CBV) -- on human skin cell
lines. CBD was found to be the most effective
at targeting unwanted DNA activity, followed by
CBG. Cancer is one of the world's leading causes
of death and is characterized by uncontrolled growth of cells in
the body. Coffee appears to be protective against two types of
cancer... liver cancer and colorectal cancer. Liver cancer is the
third leading cause of cancer death in the world, while colorectal
cancer ranks fourth. Studies show that coffee drinkers have up to a
40% lower risk of liver cancer.
While our company has now entered into a new Cannabis
marketplace, we here at Metatron firmly believed it was to the
company's benefit to move forward with this CANN-A-COFFEE line, as
we endeavor to create a full line of new health and wellness
products that will grow as the company grows in order to assure
investor value in the company.
Metatron, Inc. has introduced Series B Preferred
Shares
Metatron approved investors can acquire Series B shares in
blocks of various sizes. The first-round investors will receive the
highest discount. Series B shares can be redeemed through the
Company, are immune to reverse splits, and will convert at 1 B
share to 50,000 common shares. For more information, please
visit metatronstock.com.
Metatron's Apps:
iTunes: https://itunes.apple.com/us/artist/i-mobilize-inc./id325075390
Google Play: https://play.google.com/store/apps/developer?id=Metatron+Inc
Facebook: http://www.facebook.com/metatroninc
Twitter: http://twitter.com/metatroninc
News: http://metatroninc.com/blog
Forward-Looking Statements: Any statements made in this press
release which are not historical facts contain certain
forward-looking statements, as such term is defined in the Private
Litigation Reform Act of 1995, concerning potential developments
affecting the business, prospects, financial condition and other
aspects of the company to which this release pertains. These
forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause our actual results
of the specific items described in this release, and the company's
operations generally, to differ materially from what is projected
in such forward-looking statements. Although such statements are
based upon the best judgments of management of the company as of
the date of this release, significant deviations in magnitude,
timing and other factors may result from business risks and
uncertainties including, without limitation, the company's need for
additional financing, which is not assured and which may result in
dilution of shareholders, the company's status as a small company
with a limited operating history, dependence on third parties and
the continuing popularity of the iOS operating system, general
market and economic conditions, technical factors, receipt of
revenues, and other factors, many of which are beyond the control
of the company. Although we believe that the expectations reflected
in the forward-looking statements are reasonable, we cannot
guarantee future results, levels of activity, performance, or
achievements. Moreover, neither we nor any other person assumes
responsibility for the accuracy and completeness of such
statements, and we disclaim any obligation to update information
contained in any forward-looking statement. Metatron does not grow,
sell or distribute any substances that violate United States Law or
the Controlled Substances Act.